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Abstract
Objectives: Health-related quality of life after kidney
transplant in adolescents is a major concern;
nevertheless, there is a paucity of data on the
variables that have an effect on it. This study
evaluated the extent to which socioeconomic,
clinical, and psychological characteristics explain the
variance in the health-related quality of life of
adolescent Iranian kidney transplant recipients.
Materials and Methods: Into a hierarchical regression
analysis, the cross-sectional socioeconomic, clinical,
and psychological characteristics were entered
among 55 adolescent Iranian kidney transplant
recipients.
Results: The relative predictive power of
socioeconomic, clinical, and psychological variables
with respect to health-related quality of life was
21.8% (P = .088), 21.2% (P = .014), and 27.6% 
(P = .001). 
Conclusions: Psychological factors had a greater
relative predictive power in postrenal transplant
health-related quality of life of adolescents than did
the socioeconomic and clinical characteristics.
Further research should target to improve the
health-related quality of life in adolescent kidney
recipients by psychological intervention.
Key words: Health-related quality of life, Adolescent,
Kidney transplant, End-stage renal disease 
Introduction
Kidney transplant is the treatment of choice for
adolescents with end-stage renal disease (ESRD)
inasmuch as it confers freedom from dialysis, paves
the way for normal growth,1 contributes to a more
regular lifestyle,2 enhances school performance,3
reduces cost of dialysis,4 and alleviates family stress.5
In Iran, about 300 adolescents have received their
first renal transplant before 2003.6
Medical modalities often tend to predicate the
restoration of general health on the improvement in
health-related quality of life.7 Indeed, an evaluation
of health-related quality of life carries a great deal of
weight8 to the extent that nephrologists consider
health-related quality of life as a main outcome in the
treatment efficiency assessment9 of such cases as
kidney transplant.10
Unfortunately, a scarcity of data on the variables
that have some bearing on health-related quality of
life in renal transplanted patients has hampered
efforts to carry out more detailed analyses.11 What
exacerbates the situation is the inclination on the part
of researchers to lump together the data of young
samples into large age groups, rendering a
distinction between information on health-related
quality of life in adolescence and in young adulthood
difficult.12-14 Therefore, we sought to conduct the
present study in adolescent kidney-transplant
recipients to answer the following question: Of the
socioeconomic, clinical, and psychological factors,
which one gives a better account for the changes in
health-related quality of life? 
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Material and Methods
This cross-sectional study was carried out in
Baqiyatallah Hospital, Tehran, Iran, in 2006. This
study was approved by the institutional review
board of Baqiyatallah University of Medical Sciences.
The objects of the study were fully and clearly
explained to both the adolescents and their parents
before written informed consent was obtained from
the subjects and their parents. The study conforms to
the ethical guidelines of the 1975 Helsinki
Declaration.
From 60 invited adolescents, 55 adolescents
agreed to participate in our study. Those who did not
participate in this survey were not significantly
different from others by means of age, sex, ESRD
cause, and duration from transplant (P > .05). All
participants were Iranian adolescents (< 18 years of
age) who had undergone their first kidney transplant
at least 6 months before commencement of the study
and had a functioning graft at the time of the study.
The exclusion criteria were a history of other organ
transplants and being of a non-Iranian nationality.
Participants were selected via consecutive sampling.
A checklist including age, sex, education level
(primary school or high school), monthly family
income (less or greater than USD $300), ESRD cause
(glomerulonephritis, congenital disorders, others
causes, or unknown), history of dialysis before
transplant, Hospital Anxiety Depression Scale
(HADS), and Short Form-36 (SF36) was completed
for all participants. Socioeconomic factors were
entered in the first block (age, sex, education level,
and family income), and the clinical factors (ESRD
duration, ESRD cause, and history of dialysis before
transplant), and HADS-anxiety and depression
scores were entered in the second and third blocks. 
The HADS is a tool for measuring the symptoms
of anxiety and depression; it contains 14 items: 7 for
anxiety and 7 for depression. Each item is scored
from 0 to 3, giving a maximal score of 21 for anxiety
and depression. Scores of ≥ 11 on either subscale are
considered a significant case of psychological
morbidity (clinical caseness).15 A translated-into-
Farsi version of HADS, which had been previously
validated for the Iranian population16 was used in
Iranian renal recipients.17, 18
The SF-36 consists of 36 items for calculating the
scores for 8 subscales representing physical
functioning, social functioning, role limitations
owing to physical health problems, role limitations
attributable to emotional problems, mental health,
vitality, bodily pain, and general health perceptions.
The scores ranged between 0 and 100, with a higher
score indicating a better health-related quality of life.
The physical and mental components of the 8
subscales are combined into a physical composite
score and a mental composite score.19 The SF-36 has
proven reliability and validity for renal transplant
patients20 and also can be used in adolescents.21 A
translated-into-Farsi version, which had been
previously authenticated22 and used to evaluate
health-related quality of life in Iranian kidney
transplant recipients.23, 24
Sex, education level, family income, history of
dialysis before transplant, and ESRD cause were
reported as frequency and percentage. The median
(interquartile range) of ESRD duration was
considered for all the patients. Also, mean (± SD) was
applied for the assessment of the SF-36 subscales. All
the patients were considered to have a total score 
of anxiety and depression ≥ 11 = present and 
< 11 = absent. 
The appropriate material and methods having
been applied, answers were sought to the following
queries: In the first step, the independent sample t
test and 1-way analysis of variance were drawn upon
to find out if there was any association between
health-related quality of life and different
socioeconomic characteristics (sex, education level,
and family income), clinical variables (history of
dialysis before transplant, ESRD cause, and ESRD
duration), and psychological status (anxiety and
depression). The Pearson correlation coefficient test
also was used to determine if there was a correlation
between the SF-36 total score and age, ESRD
duration, and the HADS anxiety and depression
score. In the second step, a hierarchical regression
analysis containing the 3 factors of socioeconomic
(age, sex, education level, and family income),
clinical (ESRD duration, ESRD cause, and history of
dialysis before transplant), and psychological status
(HADS anxiety and depression score) was used to
explore the extent that socioeconomic, clinical, and
psychological factors can explain the variance in
health-related quality of life. Statistical analyses were
performed with SPSS software for Windows
(Statistical Product and Service Solutions, version
13.0, SSPS Inc, Chicago, IL, USA). P values less than
.05 were considered significant.
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Results
Participants:
Our study population comprised 34 boys (61.8%) and
21 girls (38.2%) between 11 and 18 years of age (mean
[± SD] 14.2 ± 3.0 years). The frequency of a primary
and high school education level was 32 (58.2%) and
23 (41.8%). The frequency of a monthly family
income lower than USD $300 was 43 (78.2%). In
addition, the frequencies of ESRD cause for
glomerulonephritis, congenital disorder, others
causes, and unknown were 15 (27.5%), 10 (18.2%), 
6 (10.9%), and 24 (43.4%). From a total of 55 subjects,
38 (69.1%) had a history of dialysis before transplant.
The median (quartile 25-quartile 75) of ESRD
duration was 24 months (range, 10-69 months).
Health-related quality of life:
The mean (± SD) of bodily pain was 73.40 ± 26.77.
The other means (± SD) of the SF-36 subscales are
depicted in Table 1.
The mean of the SF-36 total was poorer in the
males (62.34 ± 13.47) than that in the females 
(70.33 ± 14.03) (P = .040). Similarly, the SF-36 mean
was lower in the patients with a monthly family
income under USD $300 (range, $62.47 ± $13.69) than
that in those of at least USD $300 (range, 
$75.84 ± $10.45) (P = .003). Patients with a HADS
anxiety score above 11 had a lower mean SF-36 
(51.15 ± 13.08) than did those who had a HADS
anxiety below 11 (67.40 ± 13.82) (P = .018). Also,
patients with a HADS depression score above 11 had
a lower mean of SF-36 (44.13 ± 13.46) by comparison
with those who had a HADS depression score below
11 (67.55 ± 12.85) (P = .001) (Table 2). 
The total score of SF-36 had an inverse correlation
with the HADS depression score (r = -0.553, P < .001)
and a direct correlation with ESRD duration 
(r = 0.330, P = .016). The SF-36 total had no significant
correlation with age (r = 146, P = .289) and the HADS
anxiety score (r = -0.272, P = .089). Correlations
between age, ESRD duration, psychological score,
and SF-36 scores are shown in Table 3.
Associations between health-related quality of life
and different variables:
Sex (P = .011), and monthly family income (P = .009)
from the socioeconomic factors, ESRD duration 
(P = .018) from the clinical factors, and the HADS
depression score (P = .001) from the psychological
factors were predictors of the SF-36 total score.
Socioeconomic, clinical, and psychological factors
table 1. Mean (± SD) scores of SF-36 subscales in adolescent transplant
recipients.
Subscale Mean (± SD)
Physical function 68.45 ± 28.73
Role limitations 71.25 ± 26.66
Bodily pain 73.40 ± 26.77
Social function 73.18 ± 25.50
General mental health 57.38 ± 16.00
Role limitations owing to emotional problem 67.57 ± 28.89
Vitality energy or fatigue 59.72 ± 15.58
General health perceptions 57.75 ± 20.98
Physical component score 65.84 ± 16.70
Mental component score 61.29 ± 13.13
SF-36 TOTAL 65.39 ± 14.11
table 2. Comparisons between the means (±SD) of SF-36 and HADS scores in subpopulations in terms of socioeconomic and
clinical variables.
HRQoL Anxiety Depression 
Mean ± SD P Mean ± SD P Mean ± SD P
Sex* Male
(n=34) 62.34 ± 13.47 .040 6.28 ± 4.11 .548 5.62 ± 4.73 .055
Female
(n=21) 70.33 ± 14.03 5.40 ± 4.98 3.13 ± 2.16
Education* Primary (n=32) 62.70 ± 14.35 .096 5.73 ± 3.89 .729 4.71 ± 4.29 .941
High school (n=23) 69.13 ± 13.17 6.22 ± 5.08 4.61 ± 3.97
Monthly family income
(US dollar)* <300 (n=43) 62.47 ± 13.69 .003 6.09 ± 4.69 .643 4.89 ± 4.31 .397
>300 (n=12) 75.84 ± 10.45 5.17 ± 2.40 3.33 ± 2.34
ESRD cause† Unknown
(n=24) 63.71 ± 15.33 .718 6.31 ± 4.76 .559 6.22 ± 4.65 .232
Glomerulonephritis
(n=15) 67.17 ± 11.63 7.17 ± 5.06 3.75 ± 3.86
Genetic disorder
(n=10) 66.54 ± 15.40 4.33 ± 3.72 3.00 ± 3.79
Others
(n=6) 70.63 ± 12.32 4.80 ± .84 3.80 ± 1.30
Dialysis before* transplant Yes (n=38) 66.46 ± 12.88 .432 4.76 ± 3.72 .060 4.37 ± 4.25 .551
No (n=16) 63.14 ± 17.05 7.36 ± 4.50 5.29 ± 4.05
* Independent sample t test
† One-way ANOVA
Abbreviations: ESRD, end-stage renal disease; HADS, hospital anxiety and depression scale; HRQoL, health-related quality of life
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explained 21.8%, 21.2%, and 27.6% of the SF-36 total
score variance. The hierarchical regression analysis
of the relative predictive powers of socioeconomic,
clinical, and psychological variables with respect to
health-related quality of life in adolescent kidney-
transplant recipients are depicted in Table 4.
Discussion
Our study showed that socioeconomic, clinical, and
psychological variables altogether predict more than
70% of the variance in health-related quality of life in
adolescent renal recipients and that the psychological
variables had the highest relative predictive power of
the 3 variables.
The medical literature contains a great deal of data
devoted to explaining health-related quality of life
variance. One such study in adult kidney recipients
asserted that its model for the predicting perceived
health status could explain less than 40% and 50% of
the variance in the physical and mental components
of health-related quality of life.11 Another group of
investigators succeeded in explaining 40% of the total
variance in adult kidney recipients via a different
model.25 Pediatric kidney transplant and adult
kidney transplant differ in many ways.26 A review of
the related literature shows that whereas such
additional factors as working activities, social
support, housekeeping activities,11 and religion25
affect health-related quality of life in adults, they may
play a less important role in adolescents.
Our study of 55 Iranian adolescent renal recipients
allowed us to find an explanation for a large
percentage of health-related quality of life variance.
About 22% of the total variance in health-related
quality of life in the present study was due to
socioeconomic variables, which have been previously
shown to exert a negative effect on the health-related
quality of life of renal transplant patients.7, 27 The
socioeconomic factors reported to have a bearing on
health-related quality of life include age and sex21 in
adolescent renal recipients and education,27
socioeconomic characteristics,28 race,29 and monthly
income25 in adult kidney recipients.
The present study did not consider the predictive
power of cultural variables as regards the variance in
health-related quality of life. Be that as it may, the use
of SF-36 has previously shown that cultural issues are
not the main contributors to the said variance.30
SF-36, when properly adapted to a non-Western
culture (as was the case in the present study), is
believed to serve the purpose quite efficiently and is,
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table 3. Correlation coefficients between age, ESRD duration, psychological score, and SF-36 scores. 
ESRD Duration (mo) Anxiety Depression Physical health Mental health SF-36 Total score
component component
Age (y) 0.059 0.099 -0.001 0.202 -0.017 0.146
ESRD Duration (mo) - 0.023 -0.165 0.335* 0.054 0.330*
HADS Anxiety score - 0.556*** -0.097 -0.504** -0.272
HADS Depression score - -0.407** -0.604*** -0.553***
Physical health component score - 0.511*** 0.945***
Mental health component score - 0.718***
Pearson’s correlation coefficient
* P < .05, ** P < .01, *** P < .001, 
Abbreviations: ESRD, end-stage renal disease; HADS, hospital anxiety and depression scale
table 4. Hierarchical regression analysis of the relative predictive powers of socioeconomic, clinical, and psychological variables
with respect to HRQoL in pediatric transplant recipients. 
Model B ± SE(B) 95% CI for B Sig R2 R2 change Change 
P value
Socioeconomic block 0.218 0.218 .088
Age 0.57 ± 0.56 -0.58 to 1.72 0.320
Sex 9.06 ± 3.30 2.27 to 15.85 0.011
Family income 4.73 ± 1.68 1.27 to 8.19 0.009
Education 0.45 ± 2.30 -4.27 to 5.18 0.845
Clinical block 0.429 0.212 .014
ESRD Duration 0.08 ± 0.03 0.02 to 0.15 0.018
ESRD Cause 2.44 ± 1.74 -1.15 to 6.02 0.174
Dialysis before transplant -0.49 ± 3.66 -8.01 to 7.03 0.894
Psychological block 0.705 0.276 .001
Depression score -2.17 ± 0.57 -3.35 to -0.99 0.001
Anxiety score 0.31 ± 0.51 -0.74 to 1.36 0.545
Abbreviations: B, unstandardized regression coefficient with standard error; CI, confidence interval; ESRD, end-stage renal disease
therefore, a useful tool for the assessing the health
status outcome in most developing countries.31
Clinical variables explained 21% of the total health-
related quality of life changes in our study. It is possible
to categorize the clinical variables that affect the health-
related quality of life in kidney-transplant recipients
into 2 groups: In adolescent renal transplant recipients,
graft function,26 renal pathology,32 immuno -
suppressive regimes,33 and fatigue34 affect health-
related quality of life. In adult renal transplant
recipients, it is hypertension,35 hemoglobin,36
hematocrit, nephrosclerosis diagnosis,7 serum
creatinine,37 diabetes mellitus, comorbidity and
modality of treatment,29 failed allograft,38 and number
of hospitalizations during the dialysis period11 that
affect health-related quality of life.
Anxiety and depression accounted for
approximately 28% of the total change in health-
related quality of life in this study. It seems logical,
however, that an assessment of other psychological
variables, apart from anxiety and depression, should
increase the percentage of variance explanation. One
study posited that psychosocial factors influenced
the pediatric and young adult renal recipients’
physical health through medical treatment regimens,
nonadherence, and graft survival.39 Different organ
transplants are believed to beget different levels of
psychological morbidity, a case in point being the
psychosocial problems after kidney transplant.40
Indeed, one study reported that significant
improvement in health-related quality of life was
least marked in patients 1-5 years after transplant.3
Another study highlighted a rise in health-related
quality of life for a majority of recipients (80%) in the
physical and emotional domains after transplant; the
improvement was less remarkable in the social
domain, where only 60% reported an improvement.41
Health-related quality of life is defined by the
World Health Organization as a multidimensional
construct comprising physical, mental, social, and
economic components.42 Although this complexity is
dependent on the method of evaluation, such
variables as demographic, psychosocial, and medical
parameters have thus far been identified as the
predictors of health-related quality of life.34
The results of this study generate a hypothesis
that needs further studies. Based on this hypothesis,
enhancement in psychological health can promote
the health-related quality of life of the adolescents, a
hypothesis that must be proven by further studies. It
would be wise to restate the implications in terms of
the change in focus that the study would suggest
might lead to better quality of life.
Like other assessments of health-related quality
of life in transplant populations,43 the present study
was limited by the small sample size of adolescent
transplant recipients. Furthermore, health-related
quality of life is influenced by many not assessed
clinical variables such as duration since transplant,
contemporary renal function, medical compliance,
somatic comorbidities or immunosuppressive
regimen. Our cross-sectional design limits us to
conclude any causative association. Additionally, we
had no control group comprising health controls,
which precluded determination of the role of kidney
transplant on quality of life. In addition, our sample is
more likely to have those transplant recipients with
longer graft survival. These drawbacks might limit us
to fully generalize our results to the community of
adolescent renal transplant recipients. Larger
multicenter studies are needed to check if our results
will be verified.
Conclusions
In adolescent renal recipients, the importance of
anxiety/depression on health-related quality of life
is a little more than socioeconomic and clinical data.
Thus those with poor health-related quality of life
will benefit from psychological health evaluation. In
addition, given the paucity of data on the variables
that can predict the variance in health-related quality
of life in this group of patients, future studies seem
essential.
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